T1	Participants 147 192	children with neurodevelopmental disabilities
T2	Participants 371 454	children with neurodevelopmental disabilities including autistic spectrum disorders
T3	Participants 732 741	caregiver
T4	Participants 959 1050	Fifty-one children (age range 2-18 years) who did not respond to sleep hygiene intervention
T5	Participants 1066 1148	Fifty patients completed the crossover trial and 47 completed the open-label phase
T6	Participants 1637 1728	had treatment resistant chronic delayed sleep phase syndrome and impaired sleep maintenance
